Methotrexate (MTX), a folic acid competitor (antifolate) first synthesized in 1947, has been widely used as a chemotherapeutic agent and immune system suppressor
These can include mild soreness or bruising at the injection site, dizziness, or in very rare cases, allergic reactions
Practitioners use it for acute neuropathy, multiple neuropathy, sciatica, and rheumatoid neuropathy, in addition to general B12 deficiency
The peptide could also shed more light on the process of angiogenesis, which is important in wound healing, but also in cancer growth and development and in embryogenesis
The 1984 NIH Consensus Conference CHRIS MASTERJOHN: So if you go back to 1984, when we saw that Time magazine picture, the other thing that was going on politically and scientifically in 1984 was the NIH Consensus Conference that said that they had proven, like Time magazine cover was a reaction to the NIH consensus conference where they said, We as the scientific community now certify that we are in consensus that cholesterol is the cause of heart disease. And thats why Time magazine ran with that cover